4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-13-000334
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 1,500,000 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Singh Shawn CHIEF EXECUTIVE OFFICER | 2013-03-03 | Other acquisition · Warrant | +1,500,000 | 1,500,000 | D | ||
Loading xslF345X03/form4-03062013_010319.xml…